@article{727a2408b79242cdbafde7fc2e39ee59,
title = "Value-based insurance design in cardiology: Using {"}clinical nuance{"} to improve quality of care and contain costs",
keywords = "health spending, medication copayment, value-based insurance",
author = "Stecker, {Eric C.} and Riles, {Eric M.} and Fendrick, {A. Mark}",
note = "Funding Information: Dr. Stecker has received research grants from Medtronic , Boston Scientific , and Biotronik . Dr. Riles has reported that he has no relationships relevant to the contents of this paper to disclose. Dr. Fendrick is a consultant for Abbott, AonHewitt, AstraZeneca, Aventis Pharmaceuticals, Blue Shield of California, Center for Medicare and Medicaid Services (CMS), Genentech, GlaxoSmithKline, Health Alliance Plan, Highmark BlueCross BlueShield, Merck and Co., National Business Coalition on Health, National Pharmaceutical Council, Neocure Group LLC, Pennsylvania State Troopers Association, Pfizer Inc., POZEN, Inc., Precision Health Economics LLC, Thomson Reuters, TriZetto, and zanzors; is on the speaker's bureau of Merck and Co. and Pfizer Inc.; and has received research grants from Abbott , AstraZeneca , Aventis Pharmaceuticals , Eli Lilly , Genentech , GlaxoSmithKline , Merck and Co. , Novartis , and Pfizer Inc. ",
year = "2012",
month = oct,
day = "30",
doi = "10.1016/j.jacc.2012.07.039",
language = "English (US)",
volume = "60",
pages = "1825--1827",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "18",
}